Phenotypic and genomic analysis of serotype 3 sabin poliovirus vaccine produced in MRC-5 Cell substrate
✍ Scribed by Behnam Alirezaie; Mohammad Taqavian; Khosrow Aghaiypour; Fatemeh Esna-Ashari; Abbas Shafyi
- Book ID
- 102384017
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 132 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The cell substrate has a pivotal role in live virus vaccines production. It is necessary to evaluate the effects of the cell substrate on the properties of the propagated viruses, especially in the case of viruses which are unstable genetically such as polioviruses, by monitoring the molecular and phenotypical characteristics of harvested viruses. To investigate the presence/absence of mutation(s), the near full‐length genomic sequence of different harvests of the type 3 Sabin strain of poliovirus propagated in MRC‐5 cells were determined. The sequences were compared with genomic sequences of different virus seeds, vaccines, and OPV‐like isolates. Nearly complete genomic sequencing results, however, revealed no detectable mutations throughout the genome RNA‐plaque purified (RSO)‐derived monopool of type 3 OPVs manufactured in MRC‐5. Thirty‐six years of experience in OPV production, trend analysis, and vaccine surveillance also suggest that: (i) different monopools of serotype 3 OPV produced in MRC‐5 retained their phenotypic characteristics (temperature sensitivity and neuroattenuation), (ii) MRC‐5 cells support the production of acceptable virus yields, (iii) OPV replicated in the MRC‐5 cell substrate is a highly efficient and safe vaccine. These results confirm previous reports that MRC‐5 is a desirable cell substrate for the production of OPV. J. Med. Virol. 83:897–903, 2011. © 2011 Wiley‐Liss, Inc.